All News

The prevalence of chronic obstructive pulmonary disease (COPD) was nearly 50% higher among patients with arthritis compared with those without arthritis, even after adjusting for sociodemographic characteristics, risk behaviors, frequent distress, and asthma status.

A recently published study used linguistic analysis to investigate communication gaps between patients with Parkinson disease and physicians about off periods using a database containing dialogues recorded during regular office visits. Not only did the recordings show 4 specific areas that need improvement, they also showed a care gap between what the physicians thought they did and what actually happened.

Nivolumab (Opdivo) monotherapy is currently indicated for the treatment of patients with hepatocellular carcinoma who were previously treated with the targeted therapy sorafenib, sold as Nexavar, based on the CheckMate 040 trial. Assessing the safety and efficacy of nivolumab in combination with ipilimumab (Yervoy) among these patients, researchers have observed clinically meaningful responses and an acceptable safety profile.

A federal judge upheld the Trump administration's expansion of short-term health insurance plans that lack coverage requirements of the Affordable Care Act; politicians and others call for change after The Washington Post published a government database tracking nationwide opioid distribution along with unsealed court documents showing the role of various companies in the drug crisis; the plight of mentally ill refugees in the mix of detained undocumented immigrants is going unnoticed.

While poor sleep quality is common in patients with interstitial lung disease (ILD), it is unclear which factors other than sleep disordered breathing may contribute to poor sleep quality for these patients. A study published in ERJ Open Research found that providers should target depression and coexisting sleep disorders in order to improve sleep quality and quality of life for patients with ILD.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo